Courtney Tindle, MS., Program Manager and Director, HUMANOIDTM Center of Research Excellence (CoRE).
|"On Thursday, September 29, 2022 Senate Bill 5002, “FDA Modernization Act 2.0” was passed by unanimous and bipartisan consent. This bill changes the requisite for animal testing and allows for market approval for a new drug to use alternative methods to establish the drug's safety and effectiveness, such as organoids. Naturally, those already engaged in organoid research has been jubilant (and so are we), but we also feel the pressure to get it right because precision in disease modeling is a prerequisite before findings can be translated.
ollow us on LinkedIN